119 related articles for article (PubMed ID: 3104340)
1. Evaluation of the single radial-immunodiffusion assay for measuring the glycoprotein content of rabies vaccines.
Mayner RE; Needy CF
J Biol Stand; 1987 Jan; 15(1):1-10. PubMed ID: 3104340
[TBL] [Abstract][Full Text] [Related]
2. The effect of strain differences on the assay of rabies virus glycoprotein by single radial immunodiffusion.
Ferguson M; Wachmann B; Needy CF; Fitzgerald EA
J Biol Stand; 1987 Jan; 15(1):73-7. PubMed ID: 3104342
[TBL] [Abstract][Full Text] [Related]
3. Single radial immunodiffusion assays for the standardization of the antigenic content of rabies vaccines.
Ferguson M; Seagroatt V; Schild GC
Dev Biol Stand; 1986; 64():81-6. PubMed ID: 3098607
[TBL] [Abstract][Full Text] [Related]
4. Use of the single radial immunodiffusion test as a replacement for the NIH mouse potency test for rabies vaccine.
Fitzgerald EA; Needy CF
Dev Biol Stand; 1986; 64():73-9. PubMed ID: 3098606
[TBL] [Abstract][Full Text] [Related]
5. A single-radial-immunodiffusion technique for the assay of rabies glycoprotein antigen: application for potency tests of vaccines against rabies.
Ferguson M; Schild GC
J Gen Virol; 1982 Mar; 59(Pt 1):197-201. PubMed ID: 6802936
[TBL] [Abstract][Full Text] [Related]
6. Standardization of an enzyme immunoassay for the in vitro potency assay of inactivated tissue culture rabies vaccines: determination of the rabies virus glycoprotein with polyclonal antisera.
Thraenhart O; Ramakrishnan K
J Biol Stand; 1989 Oct; 17(4):291-309. PubMed ID: 2613705
[TBL] [Abstract][Full Text] [Related]
7. Immunity against the European bat rabies (Duvenhage) virus induced by rabies vaccines: an experimental study in mice.
Lafon M; Bourhy H; Sureau P
Vaccine; 1988 Aug; 6(4):362-8. PubMed ID: 2461007
[TBL] [Abstract][Full Text] [Related]
8. A collaborative study on the use of single radial immunodiffusion for the assay of rabies virus glycoprotein.
Ferguson M; Seagroatt V; Schild GC
J Biol Stand; 1984 Jul; 12(3):283-94. PubMed ID: 6434544
[TBL] [Abstract][Full Text] [Related]
9. A time-resolved fluoroimmunoassay to assay the rabies virus glycoprotein: application for estimation of human rabies vaccine potency.
Lin G; Chen S; Zhao H; Liang J; Deng Q; Liang R; Guo X; Chen Z; Chen B; Liu T; Wu Y
Sci Rep; 2017 Aug; 7(1):7288. PubMed ID: 28779162
[TBL] [Abstract][Full Text] [Related]
10. Effect of strain differences on the potency testing of rabies vaccines in mice.
Blancou J; Aubert MF; Cain E; Selve M; Thraenhart O; Bruckner L
J Biol Stand; 1989 Jul; 17(3):259-66. PubMed ID: 2793877
[TBL] [Abstract][Full Text] [Related]
11. Vaccination challenge studies with variants of street rabies virus isolated in Nigeria.
Okoh AE; Umoh JU; Ezeokoli CD; Addo PB
Vaccine; 1988 Feb; 6(1):19-24. PubMed ID: 3354253
[TBL] [Abstract][Full Text] [Related]
12. The influence of homologous vs. heterologous challenge virus strains on the serological test results of rabies virus neutralizing assays.
Moore SM; Ricke TA; Davis RD; Briggs DJ
Biologicals; 2005 Dec; 33(4):269-76. PubMed ID: 16168666
[TBL] [Abstract][Full Text] [Related]
13. Rabies vaccine standardization: International Collaborative Study for the Characterization of the fifth International Standard for Rabies Vaccine.
Lyng J; Bentzon MW; Ferguson M; Fitzgerald EA
Biologicals; 1992 Dec; 20(4):301-13. PubMed ID: 1305406
[TBL] [Abstract][Full Text] [Related]
14. Rabies virus-specific human T cell clones provide help for an in vitro antibody response against neutralizing antibody-inducing determinants of the viral glycoprotein.
Bunschoten H; Klapmuts RJ; Claassen IJ; Reyneveld SD; Osterhaus AD; Uytdehaag FG
J Gen Virol; 1989 Jun; 70 ( Pt 6)():1513-21. PubMed ID: 2471814
[TBL] [Abstract][Full Text] [Related]
15. Rabies virus glycoprotein. II. Biological and serological characterization.
Cox JH; Dietzschold B; Schneider LG
Infect Immun; 1977 Jun; 16(3):754-9. PubMed ID: 408269
[TBL] [Abstract][Full Text] [Related]
16. Glycoprotein from street rabies virus BD06 induces early and robust immune responses when expressed from a non-replicative adenovirus recombinant.
Wang S; Sun C; Zhang S; Zhang X; Liu Y; Wang Y; Zhang F; Wu X; Hu R
Arch Virol; 2015 Sep; 160(9):2315-23. PubMed ID: 26143474
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of standard reagents for radial-immunodiffusion assays. In vitro control of rabies vaccines.
Miceli GS; Torroba J; Torres W; Esteves Madero J; Díaz AM
Rev Inst Med Trop Sao Paulo; 2000; 42(3):153-6. PubMed ID: 10887375
[TBL] [Abstract][Full Text] [Related]
18. Antigenic variation in rabies and rabies-related viruses: cross-protection independent of glycoprotein-mediated virus-neutralizing antibody.
Dietzschold B; Tollis M; Rupprecht CE; Celis E; Koprowski H
J Infect Dis; 1987 Nov; 156(5):815-22. PubMed ID: 3655404
[TBL] [Abstract][Full Text] [Related]
19. A novel ELISA for quantification of glycoprotein in human rabies vaccines using a clinically proven virus neutralizing human monoclonal antibody.
Gairola S; Gautam M; Waghmare S
Hum Vaccin Immunother; 2020 Aug; 16(8):1857-1865. PubMed ID: 31971485
[TBL] [Abstract][Full Text] [Related]
20. In vitro rabies vaccine potency appraisal by ELISA: advantages of the immunocapture method with a neutralizing anti-glycoprotein monoclonal antibody.
Perrin P; Morgeaux S; Sureau P
Biologicals; 1990 Oct; 18(4):321-30. PubMed ID: 2285504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
